Korean Circ J.  2019 Dec;49(12):1164-1166. 10.4070/kcj.2019.0286.

The Need for Re-evaluation of PCI Practice: from Proceduralists to Clinicians

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea. cecilyk@hanmail.net
  • 2Cell Regeneration Research Center, Chonnam National University Hospital, Gwangju, Korea.
  • 3BK21 PLUS Center for Creative Biomedical Scientists, Chonnam National University Medical School, Gwangju, Korea.

Abstract

No abstract available.


MeSH Terms

Percutaneous Coronary Intervention

Reference

1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019; 139:e56–528.
2. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003; 348:1537–1545.
Article
3. Sung J, Hong KP. Descriptive study on the Korean status of percutaneous coronary intervention using National Health Insurance Service-National Sample Cohort (NHIS-NSC) database: focused on temporal trend. Korean Circ J. 2019; 49:1155–1163.
4. Kim Y, Jeong MH, Ahn Y, et al. Results of a 10-year experience in Korea using drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2018; 122:365–373.
Article
5. Sedlis SP, Hartigan PM, Teo KK, et al. Effect of PCI on long-term survival in patients with stable ischemic heart disease. N Engl J Med. 2015; 373:1937–1946.
6. Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018; 391:31–40.
7. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008; 359:677–687.
8. ISCHEMIA Trial Research Group. Maron DJ, Hochman JS, et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: rationale and design. Am Heart J. 2018; 201:124–135.
Article
9. Han S, Park GM, Kim YG, et al. Trends, characteristics, and clinical outcomes of patients undergoing percutaneous coronary intervention in Korea between 2011 and 2015. Korean Circ J. 2018; 48:310–321.
10. Shin DH, Kang HJ, Jang JS, et al. The current status of percutaneous coronary intervention in Korea: based on year 2014 & 2016 cohort of Korean Percutaneous Coronary Intervention (K-PCI) registry. Korean Circ J. 2019; 49:1136–1151.
11. Jang JS, Han KR, Moon KW, et al. The current status of percutaneous coronary intervention in Korea: based on year 2014 cohort of Korean Percutaneous Coronary Intervention (K-PCI) registry. Korean Circ J. 2017; 47:328–340.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr